Chapter 501: Chapter 287: Global Live Broadcast: The Beginning of a Great Era
Inside the operating room, Wu Ting was the lead surgeon, with Dean James assisting him.
After integrating several of He Guangzong’s skill traits, Wu Ting’s surgical abilities had undergone another qualitative leap.
In certain fine-tuned maneuvers, even James found himself lacking in comparison.
’Such incredible micro-control,’ James thought. ’Some of these steps are even blind maneuvers without a direct line of sight. How did someone so young master this?’
Dean James grew increasingly impressed with Wu Ting. It wasn’t just Wu Ting’s concepts and mindset; his clinical skills alone were enough to place him among the world’s top-tier surgeons.
Unlike the doctors from Jin Country in the observation room who were familiar with Hybrid Technology, the cardiac surgery experts and professors from the Southern District and the Southern Country District were ecstatic as they watched the live stream on the Cleveland Hospital’s official website.
The conventional treatment for an aortic aneurysm is an open procedure involving aneurysm resection combined with an artificial vessel graft. The risks of such a surgery include significant trauma and numerous complications.
Furthermore, it requires aortic clamping, making the procedure relatively complex. However, this surgery led by Dean James showed these international experts a completely different approach.
"Combining traditional surgical techniques with interventional therapy using endovascular repair... this truly is a brand-new concept."
"Who on earth is this lead surgeon?"
Because the Cleveland official website was only streaming the surgical footage without introducing the specific doctors, these experts were all very curious.
When the special covered stent graft was used to block the aneurysm, the experts were all blown away.
In particular, Wu Ting’s controllable, adjustable, self-expanding delivery system was crucial. The patient’s aneurysm was in a hidden location, the vessel wall itself was severely calcified, and the mural thrombus within the aneurysmal sac exceeded 50%. It would have been impossible to complete the delivery using only a conventional stiff guidewire and manual manipulation.
If forced, the excessive pressure could easily have damaged the aortic wall. But the head of Wu Ting’s adjustable delivery system was like a little fish with eyes, effortlessly dodging obstacles, slipping through, and reaching the precise location.
Endovascular repair is an emerging technology, and it wasn’t as if these international teams hadn’t performed related surgeries before.
However, this was the first time they had seen it combined with an adjustable delivery system, which completely compensated for the greatest drawbacks of this surgery: operational and access limitations.
Moreover, these experienced experts and professors also saw the expandability of this new auxiliary vascular stent and adjustable delivery system.
Take the treatment of An Qier’s rare, hidden aneurysm for example. It offered a new path for older patients with multiple underlying conditions who could not tolerate traditional open-abdominal surgery.
What was most stunning was the use of the bioresorbable polymer vascular stent. With this new type of stent, there was no need to worry about retrieval. Under the adjustable self-expanding delivery system, it also solved the biggest difficulties and pain points of interventional surgery and endovascular repair: endoleaks, stent migration, stent infection, stent occlusion, and other adverse events!
...
...
At the Royal Brompton Hospital in Yun Country, Professor Livingston, the director of the Cardiovascular Surgery Center, was also watching the entire live stream of the surgery.
The Royal Brompton Hospital was the best specialist heart hospital in the entire Southern Continent.
And Livingston was the center’s most world-renowned surgeon. He was also the pioneer and leader of heart transplant surgery in Yun Country.
Livingston was also the dedicated physician to the Yun Country royal family’s Princess Consort. Many old photos of him with the Princess Consort had made him a household name across the Southern Continent.
The Cardiac Surgery Research Center led by Livingston published five to six hundred articles in scientific journals every year.
Every year, surgeons at the Royal Brompton Hospital not only performed 2,400 coronary angioplasties and 1,200 coronary artery bypass grafts, but also provided treatment for 2,000 patients with respiratory failure.
It could be said that in the field of aortic disease, the Royal Brompton Hospital was the authority and leader.
Over the years, various vascular stents had been developed. The third-generation drug-eluting metal stent was born at the Royal Brompton Hospital, and Livingston had been its main proponent at the time.
The development of vascular stents had been incredibly rapid.
The first generation: simple balloon angioplasty. Because the balloon was removed after expansion, arterial restenosis occurred very easily.
The second generation: bare-metal stents. They required lifelong medication, affected the vessel’s natural function, and had extremely high rates of in-stent thrombosis and arterial restenosis.
The third generation: drug-eluting metal stents, which are currently the mainstream stents used both internationally and domestically. They also required lifelong medication and affected the vessel’s natural function, but they relatively lowered the risk of thrombosis and arterial restenosis.
But Wu Ting’s fourth-generation stent allowed for selecting a model with a specific absorption time based on the patient’s condition. Medication was only required during the dissolution period. Afterward, the vessel’s natural function would be restored, and thrombosis and restenosis were essentially eliminated.
The most incredible part was the stent’s ability to repair vessel function and then be reabsorbed. Even if new lesions appeared, repeated interventions were possible. ’What a perfect vascular stent!’
For the past two years, he had also been seeking a revolution in stent technology, but he never expected to see this public demonstration of a fourth-generation bioresorbable polymer vascular stent on Cleveland’s official website.
Professor Livingston was immediately intrigued. After the surgery, he was going to call his old friend, James.
Livingston was deeply fascinated by the doctor who pioneered this new technology and decided he must pay him a personal visit.
After that, he would even invite this doctor to the Southern Continent for an academic exchange.
He planned to introduce this fourth-generation vascular stent technology as soon as possible. This was the future!
Although Livingston was no longer young, he had always been at the forefront of medicine.
His status in the Southern Continent’s cardiovascular surgery field was comparable to Dean James’s status in the Southern Country, and perhaps even surpassed it.
Professor Livingston was a fellow of the Southern Continent College of Cardiology, the president of the South Continent Thoracic and Cardiovascular Surgery Association, and a senior researcher at the Yun Country National Health Institute.
He was the former president of the Southern Continent Society for Percutaneous Cardiovascular Interventions and the leader of the Complex Coronary Artery Disease Research Program at the Southern Continent Cardiovascular Biomedical Research Institute.
He also served as a professor of clinical cardiology at the Buyun Country Institute of Technology.
This was a pivotal figure. He was also the vice president of the International Cardiovascular Surgery Association.
If Livingston were to endorse the fourth-generation stent from Wu’s Pharmaceutical Company, it would absolutely be able to penetrate the Southern Continent market completely.
...
...
With the live stream broadcast simultaneously on the official websites of the Cleveland Medical College and the International Cardiovascular Surgery Association, doctors from all over the world were learning about it and paying close attention.
First, Wu Ting’s fourth-generation bioresorbable polymer vascular stent had truly opened the doors of cardiac surgery to the entire world.
Previously, the papers published under Wu Ting’s name alone had a relatively small impact. But this time, with an official surgical demonstration by Cleveland Hospital, Dean James, and the International Cardiovascular Surgery Association, it meant that after today, the fourth-generation bioresorbable polymer vascular stent would officially become the mainstream stent worldwide.
The third-generation drug-eluting metal stents would officially exit the historical stage.
In addition, the brand-new surgical approach demonstrated by the lead surgeon of this operation—a combined strategy of traditional surgery and interventional therapy—also made its official debut on the international stage. However, this new Surgical Technique still needed more case studies to be fully showcased.
The surgery itself ended quickly, but its impact would be long-lasting!
Tokyo University Hospital in Hai Country, Xinluo Country Central Hospital, Alpha Hospital in Maming Country, Moer University Hospital in Mexico, and others—the cardiac surgery teams from the Jinzhou region who were about to participate in the Asia-Pacific Region’s international skills competition were also paying close attention to this brand-new surgery that Dean James was heavily promoting.
Unfortunately, thanks to Dean James’s deliberate planning, the public currently only knew that there was such a surgery, such a team, and such a young doctor. But the identity of the lead surgeon and the location of the operation were still being kept secret.
It had to be said that Dean James and Steve, the Vice President of Johnson & Johnson Pharmaceutical Group, were both masters at manipulating people’s hearts and controlling the flow of online traffic.
After Wu Ting and James’s live surgery was completed, Wu Ting’s subsequent lecture on the emerging discipline of Hybrid Technology would only be presented internally within the research center.
The full, formal launch of this new technological discipline would happen at the upcoming International Cardiovascular Surgery Association conference!
In other words, today’s surgery—packed with value, substance, and revolutionary change—was merely an appetizer, a preview of the major event to come at the International Cardiovascular Surgery Association conference!
In front of their screens, those top-tier experts and professors were left itching with curiosity by Dean James’s move.
It seemed they would have to wait for the International Cardiovascular Surgery Association conference to formally and comprehensively learn about the new discipline being born from this surgery.
...
...
At this moment, the luckiest people were undoubtedly the doctors at the Johnson & Johnson Group’s research center.
They would be the first to get the inside scoop. James’s assistant arranged for everyone to proceed in an orderly fashion to a specially prepared lecture hall.
Amidst everyone’s anticipation, Dean James brought Wu Ting before the crowd.
Seeing the youthful Wu Ting, everyone, whether they were familiar with him or not, broke into enthusiastic applause to welcome him.
Even An Qier’s grandfather, Professor Owen, who had come along on a whim, rose to his feet and applauded excitedly.
"First, I’d like to welcome all the experts and professors who have come to participate in today’s exchange..."
"Before we proceed to the next stage, the lecture on the new Hybrid Technology discipline, Director Wu and I have some good news for you all. An Qier’s surgery was a complete success!"
Dean James and Wu Ting, one old and one young, stood together, looking exceptionally harmonious and close, like a pair of friends who had transcended their age gap and known each other for years.
The media, invited by Dean James and the Johnson & Johnson Group, also began filming and recording.
The shot of Wu Ting and Dean James reporting together was forever frozen in time.
This was destined to be the dawn of a great new era!
If you find any errors ( broken links, non-standard content, etc.. ), Please let us know < report chapter > so we can fix it as soon as possible.